Intralesional immunotherapy using tuberculin PPD in the treatment of palmoplantar and periungual warts

Asian Biomedicine

Volumn 3, Issue 6, 2009, Pages 739-743

  Wananukul, Siriwan ^a   Chatproedprai, Susheera ^a   Kittiratsacha, Pornpat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Immunotherapy; Tuberculin PPD; Warts

Indexed keywords

CORTICOSTEROID; TUBERCULIN;

ADOLESCENT; ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CHILD; CRYOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; PALMOPLANTAR WART; PERIUNGUAL WART; PRESCHOOL CHILD; PURPURA; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR REGRESSION; VERRUCA VULGARIS;

EID: 79952165220     PISSN: 19057415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bacelier R, Johnson SM. Cutaneous warts an evidence-base approach to therapy. Am Fam Physican. 2005;72:647-52. (Pubitemid 41176773)
2. Gibbs S, Harvey I, Sterling JC, Stark R. Local treatments for cutaneous warts. Cochrane database Syst Rev. 2006;3: CD001781.
3. Sterling JG, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001;140:4-11. (Pubitemid 32162085)
4. Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4:273-93. (Pubitemid 46170319)
5. Keogh-Brown MR, Fordham RJ, Thomas KS, Bachmann RC, Holland RC, Avery AJ, et al. To freeze or not to freeze: a cost-effectiveness analysis of wart treatment. Br J Dermatol. 2007;156:687-92. (Pubitemid 46452378)
6. Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review. Br J Dermatol. 2002;325:461-9.
7. Higgins E, du Vivier A. Topical immunotherapy: unapproved uses, dosages or indication. Clin Dermatol. 2002;20:515-21.
8. Rampen FH, Steijlen PM. Diphencyprone in the management to refractory palmoplantar and periungual warts: an open study. Dermatology. 1996;193:236-8. (Pubitemid 26361527)
9. Buckley DA, Keane FM, Munn SE. Recalcitrant viral wart treated by diphencyprone immunotherapy. Br J Dermatol. 1999;142:292-6. (Pubitemid 29397998)
10. Iijima S, Otsuka F. Contact immunotherapy with squaric acid dibutylester for warts. Dermatology. 1993;187:115-8. (Pubitemid 23209579)
11. Horn TH, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, candida and trichophyton skin test antigens. Arch Dermatol. 2005;141:589-94.
12. Johnson SM, Horn TD. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy. J Drugs Dermatol. 2004;3:263-5.
13. Cliffton MM, Johnson SM, Roberson PK, Kincannon J, Horn TD. Immunotherapy for recalcitrant warts in children using intralesional mumps or candida antigens. Pediatr Dermatol. 2003;20:268-71. (Pubitemid 36736791)
14. Maronn M, Salm C, Lyon V, Galbraith S. One-year experience with Candida antigen immunotherapy for warts and molluscum. Pediatr Dermatol. 2008;25:189-92. (Pubitemid 351579600)
15. Perman M, Sterling JB, Gaspari A. The painful purple digit: an alarming complication of Candida albicans antigen treatment of recalcitrant warts. Dermatitis. 2005;16:38-40. (Pubitemid 40667530)